BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 1281303)

  • 1. Platelet activation leads to increased c-src kinase activity and association of c-src with an 85-kDa tyrosine phosphoprotein.
    Wong S; Reynolds AB; Papkoff J
    Oncogene; 1992 Dec; 7(12):2407-15. PubMed ID: 1281303
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification and characterization of a cytoskeleton-associated, epidermal growth factor sensitive pp60c-src substrate.
    Maa MC; Wilson LK; Moyers JS; Vines RR; Parsons JT; Parsons SJ
    Oncogene; 1992 Dec; 7(12):2429-38. PubMed ID: 1281304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of phospholipase D of human platelets by protein tyrosine kinase inhibitors.
    Martinson EA; Scheible S; Presek P
    Cell Mol Biol (Noisy-le-grand); 1994 Jul; 40(5):627-34. PubMed ID: 7526916
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective association of the tyrosine kinases Src, Fyn, and Lyn with integrin-rich actin cytoskeletons of activated, nonaggregated platelets.
    Bertagnolli ME; Hudson LA; Stetsenko GY
    Biochem Biophys Res Commun; 1999 Jul; 260(3):790-8. PubMed ID: 10403844
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tyrosine kinase blockers: new platelet activation inhibitors.
    Rendu F; Eldor A; Grelac F; Levy-Toledano S; Levitzki A
    Blood Coagul Fibrinolysis; 1990 Dec; 1(6):713-6. PubMed ID: 2133252
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Platelet-activating factor stimulation of tyrosine kinase and its relationship to phospholipase C in rabbit platelets: studies with genistein and monoclonal antibody to phosphotyrosine.
    Dhar A; Paul AK; Shukla SD
    Mol Pharmacol; 1990 Apr; 37(4):519-25. PubMed ID: 1691437
    [TBL] [Abstract][Full Text] [Related]  

  • 7. KRDS, a peptide derived from human lactotransferrin, inhibits thrombin-induced thromboxane synthesis by a cyclooxygenase-independent mechanism.
    Lévy-Toledano S; Grelac F; Caen JP; Maclouf J
    Thromb Haemost; 1995 May; 73(5):857-61. PubMed ID: 7482416
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-CD9 monoclonal antibody activates p72syk in human platelets.
    Ozaki Y; Satoh K; Kuroda K; Qi R; Yatomi Y; Yanagi S; Sada K; Yamamura H; Yanabu M; Nomura S
    J Biol Chem; 1995 Jun; 270(25):15119-24. PubMed ID: 7541034
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Most of the substrates of oncogenic viral tyrosine protein kinases can be phosphorylated by cellular tyrosine protein kinases in normal cells.
    Kamps MP; Sefton BM
    Oncogene Res; 1988 Sep; 3(2):105-15. PubMed ID: 2465525
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytoskeletal changes in platelets induced by thrombin and phorbol myristate acetate (PMA).
    Chen R; Liang N
    Cell Biol Int; 1998; 22(6):429-35. PubMed ID: 10328851
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of c-Src in cellular events associated with colony-stimulating factor-1-induced spreading in osteoclasts.
    Insogna K; Tanaka S; Neff L; Horne W; Levy J; Baron R
    Mol Reprod Dev; 1997 Jan; 46(1):104-8. PubMed ID: 8981371
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gi-mediated activation of the Ras/MAP kinase pathway involves a 100 kDa tyrosine-phosphorylated Grb2 SH3 binding protein, but not Src nor Shc.
    Kranenburg O; Verlaan I; Hordijk PL; Moolenaar WH
    EMBO J; 1997 Jun; 16(11):3097-105. PubMed ID: 9214627
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclic AMP-insensitive activation of c-Src and Syk protein-tyrosine kinases through platelet membrane glycoprotein VI.
    Ichinohe T; Takayama H; Ezumi Y; Yanagi S; Yamamura H; Okuma M
    J Biol Chem; 1995 Nov; 270(47):28029-36. PubMed ID: 7499287
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of p60fyn in human platelets.
    Horak ID; Corcoran ML; Thompson PA; Wahl LM; Bolen JB
    Oncogene; 1990 Apr; 5(4):597-602. PubMed ID: 2183161
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased tyrosine kinase activity in pp60c-src immunoprecipitate from platelet activating factor stimulated human platelets: in vitro phosphorylation of a synthetic peptide.
    Zhu CY; Shukla SD
    Life Sci; 1993; 53(2):175-83. PubMed ID: 7685849
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The protein tyrosine kinase pp60c-src is activated upon platelet stimulation.
    Liebenhoff U; Greinacher A; Presek P
    Cell Mol Biol (Noisy-le-grand); 1994 Jul; 40(5):645-52. PubMed ID: 7526917
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thrombin-stimulated phosphatidylinositol 3-kinase activity in platelets is associated with activation of PYK2 tyrosine kinase: activation of both enzymes is aggregation independent.
    Sayed MR; Sheid MP; Stevens CM; Duronio V
    J Cell Physiol; 2000 Jun; 183(3):314-20. PubMed ID: 10797305
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epinephrine induces association of pp60src with Gi alpha in human platelets.
    Torti M; Crouch MF; Lapetina EG
    Biochem Biophys Res Commun; 1992 Jul; 186(1):440-7. PubMed ID: 1378727
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thrombin treatment induces rapid changes in tyrosine phosphorylation in platelets.
    Golden A; Brugge JS
    Proc Natl Acad Sci U S A; 1989 Feb; 86(3):901-5. PubMed ID: 2464830
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tyrosine phosphorylation events during different stages of collagen-platelet activation.
    Kralisz U; Cierniewski CS
    Biochim Biophys Acta; 1998 Oct; 1405(1-3):128-38. PubMed ID: 9784623
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.